Skip to content

Machine learning-based noninvasive assays explore the use of volatile organic compounds for clinical diagnosis and evaluation of gastrointestinal tumors

Machine learning-based noninvasive assays explore the use of volatile organic compounds for clinical diagnosis and evaluation of digestive diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073117
Enrollment
Unknown
Registered
2023-07-02
Start date
2023-07-01
Completion date
Unknown
Last updated
2023-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

Sponsors

Huadong Hospital Affiliated to Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 80 Years

Inclusion criteria

Inclusion criteria: Colorectal cancer inclusion criteria (1) age between 25 and 80 years; (2) Adenocarcinoma was confirmed by pathology (3) Agree to participate in the experiment and sign the experiment notice. The inclusion criteria of healthy control group were colonoscopy and imaging examination, indicating no history of colorectal cancer and other organic diseases, and no history of other malignant tumors or infectious diseases. Inclusion criteria for gastric cancer :(1) aged between 25 and 80 years; (2) Adenocarcinoma was confirmed by pathology (3) Agree to participate in the experiment and sign the experiment notice. The inclusion criteria of healthy control group were gastroscopy and imaging examination, indicating no gastric cancer and other organic diseases, no history of other malignant tumors or infectious diseases.

Exclusion criteria

Exclusion criteria: (1) Pregnancy, lactation or possibility of pregnancy; (2) There is a confirmed congenital disease; (3) Have a history of mental illness; (4)Peptic ulcer active stage; ; (5) Symptoms of acute disease occurred 2 weeks before enrollment; (6) History of infection; (7) Patients who have previously received treatment options (chemotherapy, radiotherapy or combination therapy); (8) Severe COPD; (9) Unstable diabetes mellitus, (10) Patients with other malignant tumors.

Design outcomes

Primary

MeasureTime frame
Volatile organic compounds;sensitivity;specificity;

Secondary

MeasureTime frame
16s of intestinal flora;

Countries

China

Contacts

Public ContactXiaowen Li

Huadong Hospital Affiliated to Fudan University

muziyu3030@126.com+86 137 7443 1973

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026